BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2573 related articles for article (PubMed ID: 11130078)

  • 21. The role of Toll-like receptors and MyD88 in innate immune responses.
    Akira S; Hoshino K; Kaisho T
    J Endotoxin Res; 2000; 6(5):383-7. PubMed ID: 11521059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of toll-like receptor (TLR)2, TLR4, and TLR9 in the mammalian cornea induces MyD88-dependent corneal inflammation.
    Johnson AC; Heinzel FP; Diaconu E; Sun Y; Hise AG; Golenbock D; Lass JH; Pearlman E
    Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):589-95. PubMed ID: 15671286
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens.
    Underhill DM; Ozinsky A; Hajjar AM; Stevens A; Wilson CB; Bassetti M; Aderem A
    Nature; 1999 Oct; 401(6755):811-5. PubMed ID: 10548109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
    Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
    Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.
    Bauer S; Kirschning CJ; Häcker H; Redecke V; Hausmann S; Akira S; Wagner H; Lipford GB
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9237-42. PubMed ID: 11470918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
    Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
    Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The critical DNA flanking sequences of a CpG oligodeoxynucleotide, but not the 6 base CpG motif, can be replaced with RNA without quantitative or qualitative changes in Toll-like receptor 9-mediated activity.
    Sen G; Flora M; Chattopadhyay G; Klinman DM; Lees A; Mond JJ; Snapper CM
    Cell Immunol; 2004; 232(1-2):64-74. PubMed ID: 15922717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Toll-like receptors and innate immune system].
    Akira S
    Tanpakushitsu Kakusan Koso; 2001 Mar; 46(4 Suppl):562-6. PubMed ID: 11268661
    [No Abstract]   [Full Text] [Related]  

  • 30. Bacterial DNA activates human neutrophils by a CpG-independent pathway.
    Trevani AS; Chorny A; Salamone G; Vermeulen M; Gamberale R; Schettini J; Raiden S; Geffner J
    Eur J Immunol; 2003 Nov; 33(11):3164-74. PubMed ID: 14579285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of TLR9 activation.
    Latz E; Visintin A; Espevik T; Golenbock DT
    J Endotoxin Res; 2004; 10(6):406-12. PubMed ID: 15588423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Augmentation of T(H)-1 type response by immunoactive AT oligonucleotide from lactic acid bacteria via Toll-like receptor 9 signaling.
    Shimosato T; Kitazawa H; Katoh S; Tohno M; Iliev ID; Nagasawa C; Kimura T; Kawai Y; Saito T
    Biochem Biophys Res Commun; 2005 Jan; 326(4):782-7. PubMed ID: 15607737
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.
    Rutz M; Metzger J; Gellert T; Luppa P; Lipford GB; Wagner H; Bauer S
    Eur J Immunol; 2004 Sep; 34(9):2541-50. PubMed ID: 15307186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation.
    Obermeier F; Dunger N; Strauch UG; Hofmann C; Bleich A; Grunwald N; Hedrich HJ; Aschenbrenner E; Schlegelberger B; Rogler G; Schölmerich J; Falk W
    Gastroenterology; 2005 Sep; 129(3):913-27. PubMed ID: 16143131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities.
    Vollmer J; Weeratna R; Payette P; Jurk M; Schetter C; Laucht M; Wader T; Tluk S; Liu M; Davis HL; Krieg AM
    Eur J Immunol; 2004 Jan; 34(1):251-62. PubMed ID: 14971051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.
    Pasare C; Medzhitov R
    Science; 2003 Feb; 299(5609):1033-6. PubMed ID: 12532024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection.
    Tabeta K; Georgel P; Janssen E; Du X; Hoebe K; Crozat K; Mudd S; Shamel L; Sovath S; Goode J; Alexopoulou L; Flavell RA; Beutler B
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3516-21. PubMed ID: 14993594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways.
    Hochrein H; Schlatter B; O'Keeffe M; Wagner C; Schmitz F; Schiemann M; Bauer S; Suter M; Wagner H
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11416-21. PubMed ID: 15272082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.
    Häcker H; Vabulas RM; Takeuchi O; Hoshino K; Akira S; Wagner H
    J Exp Med; 2000 Aug; 192(4):595-600. PubMed ID: 10952730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the type of liposome involving cytokine production induced by non-CpG Lipoplex in macrophages.
    Yasuda S; Yoshida H; Nishikawa M; Takakura Y
    Mol Pharm; 2010 Apr; 7(2):533-42. PubMed ID: 20047296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 129.